Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study

Saroj Vadhan-Raj; David C. Ford; Naomi V. Dahl; Kristine Bernard; Zhu Li; Lee F. Allen; William E. Strauss

doi:10.1002/ajh.24240

Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study

Saroj Vadhan-Raj, David C. Ford, Naomi V. Dahl, Kristine Bernard, Zhu Li, Lee F. Allen, William E. Strauss

Sarcoma Medical Oncology

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Original language	English (US)
Pages (from-to)	E3-E5
Journal	American journal of hematology
Volume	91
Issue number	2
DOIs	https://doi.org/10.1002/ajh.24240
State	Published - Feb 1 2016

ASJC Scopus subject areas

Hematology

MD Anderson CCSG core facilities

Clinical Trials Office

Access to Document

10.1002/ajh.24240

Cite this

Vadhan-Raj, S., Ford, D. C., Dahl, N. V., Bernard, K., Li, Z., Allen, L. F., & Strauss, W. E. (2016). Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study. American journal of hematology, 91(2), E3-E5. https://doi.org/10.1002/ajh.24240

Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study. / Vadhan-Raj, Saroj; Ford, David C.; Dahl, Naomi V. et al.
In: American journal of hematology, Vol. 91, No. 2, 01.02.2016, p. E3-E5.

Research output: Contribution to journal › Letter › peer-review

Vadhan-Raj, S, Ford, DC, Dahl, NV, Bernard, K, Li, Z, Allen, LF & Strauss, WE 2016, 'Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study', American journal of hematology, vol. 91, no. 2, pp. E3-E5. https://doi.org/10.1002/ajh.24240

@article{388f598775d9499abf8a1ec8936e3464,

title = "Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study",

author = "Saroj Vadhan-Raj and Ford, {David C.} and Dahl, {Naomi V.} and Kristine Bernard and Zhu Li and Allen, {Lee F.} and Strauss, {William E.}",

year = "2016",

month = feb,

day = "1",

doi = "10.1002/ajh.24240",

language = "English (US)",

volume = "91",

pages = "E3--E5",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "2",

}

TY - JOUR

T1 - Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy

T2 - Results of a phase III, open-label, 6-month extension study

AU - Vadhan-Raj, Saroj

AU - Ford, David C.

AU - Dahl, Naomi V.

AU - Bernard, Kristine

AU - Li, Zhu

AU - Allen, Lee F.

AU - Strauss, William E.

PY - 2016/2/1

Y1 - 2016/2/1

UR - http://www.scopus.com/inward/record.url?scp=84956558020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956558020&partnerID=8YFLogxK

U2 - 10.1002/ajh.24240

DO - 10.1002/ajh.24240

M3 - Letter

C2 - 26572233

AN - SCOPUS:84956558020

SN - 0361-8609

VL - 91

SP - E3-E5

JO - American journal of hematology

JF - American journal of hematology

IS - 2

ER -

Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study

ASJC Scopus subject areas

MD Anderson CCSG core facilities

Access to Document

Other files and links

Cite this